News & Events

ACRES and Task Force Dagger Foundation Partner to Improve Special Operations Forces Health

The Alliance for Clinical Research Excellence and Safety (ACRES) and the Task Force Dagger Foundation will work together to integrate and advance clinical research and healthcare for all members of the US Special Operations Command.

Interventional Concepts and ACRES Announce Alliance for Colombia

Interventional Concepts and the Alliance for Clinical Research Excellence and Safety (ACRES) partner in efforts to more firmly connect Colombia with the larger world of biomedical research, increasing opportunities for both Colombia and the clinical research enterprise.

HealthCarePoint Announces Completion of Testing on Collaborative Platform Used by ACRES
ACRES Endorses MAGI’s Standard CTA Template

Model Agreement & Guidelines International (MAGI) joins the Alliance for Clinical Research Excellence and Safety (ACRES) in working together on an effort to improve the current costly time for clinical research site study startup by bringing uniformity to the documents involved in the contract negotiation process.

ACRES and GuideStar Collaborate on Biomedical Research Site Sustainability

The Alliance for Clinical Research Excellence and Safety (ACRES) and GuideStar Clinical Trials Management to Partner on Site-Sustainability Standards, Global Site Network Registration, Site Optics and Third Party Accreditation Oversight.

ACRES Announces Second Phase of Collaborative IT Platform to Support Clinical Research

The Alliance for Clinical Research Excellence and Safety (ACRES) announces a major advance toward a shared, open information technology platform for all-user integration across the biomedical research enterprise.

Patient Advocate Jack Whelan's Article on Patient-Centricity Featured in Clinical Trials Arena
ACRES and Ethical GmbH, Switzerland to Collaborate on eAdjudication

Ethical GmbH and the Alliance for Clinical Research Excellence and Safety (ACRES) join forces in improving Centralized Endpoint Adjudication - an essential element of drug development. An initial focus is developing standards for Adjudication Committee Charters, standard adjudication workflows and operating procedures to better align these across service providers, sponsors and members of adjudication committees.

Briggs Morrison, CEO, Syndax Pharmaceuticals to Open ACRES Inaugural SYNERGY Event

Dr. Briggs Morrison, CEO of Syndax Pharmaceuticals and previously EVP and Chief Medical Officer at AstraZeneca, to participate in the Alliance for Clinical Research Excellence and Safety’s (ACRES) systems-based event aimed at improving the biomedical research enterprise.

Marken Announces Partnership with ACRES
© Copyright 2022 - ACRES - All Rights Reserved